• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MDC 0.00% $6.60

MEDLAB CLINICAL LIMITED - Charts / Financials

Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company focused on... Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company focused on the development and commercialization of a pharmaceutical delivery platform. The Company is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas, including pain management, mental health, gut health, diabetes, and allergies. The Company’s drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The Company's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress . The Company also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

refresh Created with Sketch. REFRESH
Last update - 15.59pm 22/11/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
0 0.0¢ 0   0 0.0¢ 0

Directors & Senior Management

Dr. Sean Michael Hall Chief Executive Officer, Managing Director
Mr. Kerem Kaya Chief Financial Officer, Chief Operating Officer, Company Secretary
Mr. Ian Curtinsmith Chief Information Officer
Dr. Jeremy Henson Director of Medical Research
Dr. David Rutolo Director of Science
Mr. Matthew Hudson Non-Executive Director
Mr. Laurence McAllister Non-Executive Director
Mr. Edmond Tan Non-Executive Director
Mr. Tim Walker Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
$6.60
Change
0.000(0.00%)
Mkt cap ! $15.07M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.